Back
Context Therapeutics Quote, Financials, Valuation and Earnings
Invest. Do Good. Get Rewarded. Just $0.26/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
16
CNTX
Context Therapeutics
Last Price:
1.50
Seasonality Move:
-30%
7 Day Trial
ALL ACCESS PASS
$
7
Say this - unlock as much as $1,250 every Friday
Click here for full details.Context Therapeutics Price Quote
$1.50
Context Therapeutics Key Stats
Sell
16
Context Therapeutics (CNTX)
is a Sell
Day range:
$1.47 - $1.55
52-week range:
$0.79 - $2.75
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
1.34%
Volume:
70.3K
Avg. volume:
300.8K
1-year change:
81.88%
Market cap:
$112.5M
Revenue:
$0
EPS:
$-0.91
How Much Does Context Therapeutics Make?
Data Unavailable
Is Context Therapeutics Growing As A Company?
Data Unavailable
Context Therapeutics Stock Price Performance
-
Did Context Therapeutics Stock Go Up Last Month?
Context Therapeutics share price went down by -35.9% last month -
Did CNTX's Share Price Rise Over The Last Year?
CNTX share price rose by 81.88% over the past 1 year
What Is Context Therapeutics 52-Week High & Low?
-
What Is Context Therapeutics’s 52-Week High Share Price?
Context Therapeutics has traded as high as $2.75 over the past 52 weeks -
What Is Context Therapeutics’s 52-Week Low Share Price?
Context Therapeutics has traded as low as $0.79 over the past 52 weeks
Context Therapeutics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Context Therapeutics?
-
How Much Debt Does Context Therapeutics Have?
Total long term debt quarterly is $0 -
How Much Cash Does Context Therapeutics Have?
Cash and short term investments quarterly total is $84.8M -
What Is Context Therapeutics’s Book Value Per Share?
Book value per share is 1.12
Is Context Therapeutics Cash Flow Positive?
-
What Is CNTX Cash Flow From Operations?
Cash flow from operations (TTM) is -$16.9M -
What Is Context Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $0 -
What Is Context Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is $0
Context Therapeutics Return On Invested Capital
Data Unavailable
Context Therapeutics Earnings Date & Stock Price
-
What Is Context Therapeutics's Stock Price Today?
A single share of CNTX can be purchased today for 1.50 -
What Is Context Therapeutics’s Stock Symbol?
Context Therapeutics trades on the nasdaq under the ticker symbol: CNTX -
When Is Context Therapeutics’s Next Earnings Date?
The next quarterly earnings date for Context Therapeutics is scheduled on February 28, 2025 -
When Is CNTX's next ex-dividend date?
Context Therapeutics's next ex-dividend date is November 28, 2024 -
How To Buy Context Therapeutics Stock?
You can buy Context Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Context Therapeutics Competitors
-
Who Are Context Therapeutics's Competitors?
Below is a list of companies who compete with Context Therapeutics or are related in some way:
Context Therapeutics Dividend Yield
-
What Is CNTX Dividend Yield?
Context Therapeutics’s dividend yield currently is 0% -
What Is Context Therapeutics’s Payout Ratio?
Context Therapeutics’s payout ratio is 0% -
When Did Context Therapeutics Last Pay A Dividend?
The latest dividend pay date is November 28, 2024 -
What Is Context Therapeutics’s Dividend Per Share?
Context Therapeutics pays a dividend of $0.00 per share
Context Therapeutics Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | -144.44% |
| Revenue: | 0% | 0% |
Analyst Recommendations
| Buy Recommendations: | 2 |
|---|---|
| Hold Recommendations: | 0 |
| Sell Recommendations: | 0 |
| Price Target: | 7.70 |
| Upside from Last Price: | 413.33% |